References
Share
Follow Us
Slow Progression Rate of Fibrosis in Hepatitis C Virus Patients With Persistently Normal Alanine Transaminase Activity
1. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832[ [ Link previously at www.ncbi.nlm.nih.gov ]].
2. Alter MJ, Marcolis HS, Krawczyski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905[ [ Link previously at www.ncbi.nlm.nih.gov ]].
3. Poynard T, Bedossa P, Metavir and Clinivir Cooperative Study Groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 1997; 4: 199-208[ [ Link previously at www.ncbi.nlm.nih.gov ]].
4. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995; 21: 285-290[ Abstract].
5. Stanley AJ, Haydon GH, Piris J, Jarvis LM, Hayes PC. Assessment of liver histology in patients with normal transaminase levels. Eur J Gastroenterol Hepatol 1996; 8: 869-872[ [ Link previously at www.ncbi.nlm.nih.gov ]].
6. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 397-398[ [ Link previously at www.ncbi.nlm.nih.gov ]].
7. Yuki N, Hayashi N, Takehara T, Hagiwara H, Hiramatsu N, Naito M, Kawanishi Y, et al. Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol 1994; 89: 1462-1466[ [ Link previously at www.ncbi.nlm.nih.gov ]].
8. Brillanti S, Folli M, Gaiani S, Masci C, Migloli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet 1993; 341: 464-465[ [ Link previously at www.ncbi.nlm.nih.gov ]].
9. Prieto M, Olaso V, Verdu C, Cordoba J, Gisbert C, Rayon M, Carrasco D, et al. Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction. HEPATOLOGY 1995; 22: 413-417[ [ Link previously at www.ncbi.nlm.nih.gov ]].
10. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243[ [ Link previously at www.ncbi.nlm.nih.gov ]].
11. Kodama T, Tamamki T, Katabami S, Katamuma A, Yamashita H, Azuma N, Kamijo K, et al. Histological findings in asymptomatic hepatitis C virus carriers. J Gastroenterol Hepatol 1993; 8: 403-405[ [ Link previously at www.ncbi.nlm.nih.gov ]].
12. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. HEPATOLOGY 1995; 22: 418-425[ Abstract].
13. Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Polda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ 1994; 308: 697[ [ Link previously at www.ncbi.nlm.nih.gov ]].
14. Marcellin P, Gournay J, Cymes K, Martinot M, Benhamou JP, Degott C, Erlinger S. Liver histology in asymptomatic anti-HCV patients with normal ALT levels. HEPATOLOGY 1994; 20: 255A.
15. The METAVIR Cooperative Group. Inter and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. HEPATOLOGY 1994; 20: 15-20[ Abstract].
16. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al. A comparison of three interferon alpha-2b regimens for long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332: 1457-1462[ [ Link previously at www.ncbi.nlm.nih.gov ]].
17. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293[ Abstract].
18. Morisco F, Del Vecchio-Blanco G, Tucillo C, Iasevoli P, Sessa G, Caporaso N. Levels of HCV RNA in subjects with and without HCV-related chronic liver disease [Abstract]. J Hepatol 1995; 23(Suppl): A25.
19. Payen JL, Izopet J. Le statut de porteur sain du virus de l’hépatite C existe t-il? Gastroenterol Clin Biol 1996; 20: 531-534[ [ Link previously at www.ncbi.nlm.nih.gov ]].
20. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. HEPATOLOGY 1994; 19: 871-875[ Abstract].
21. Hagiwara H, Hayashi N, Mita E, Naito M, Kashara A, Fusamoto H, Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. HEPATOLOGY 1993; 17: 545-550[ Abstract].
22. Serfaty L, Chazouillères O, Pawlotsky JM, Andréani T, Pellet C, Poupon R. Level of viremia, genotype, histological features and effect of interferon (IFN) therapy in hepatitis C virus (HCV) carriers with persistently normal ALT activity. HEPATOLOGY 1994; 20: 165A.
Copyright © 1998 by the American Association for the Study of Liver Diseases.
